# Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant

> **NCT02084446** · PHASE4 · COMPLETED · sponsor: **Ronaldo de Matos Esmeraldo, MD** · enrollment: 120 (actual)

## Conditions studied

- Transplantation Infection
- Cytomegalovirus Infections

## Interventions

- **DRUG:** Everolimus
- **DRUG:** Very Low Tacrolimus
- **DRUG:** Low Tacrolimus
- **DRUG:** Steroids
- **DRUG:** Thymoglobulin
- **DRUG:** Sodium Mycophenolate

## Key facts

- **NCT ID:** NCT02084446
- **Lead sponsor:** Ronaldo de Matos Esmeraldo, MD
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2014-07
- **Final completion:** 2017-07
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02084446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02084446, "Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02084446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*